Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
2.1 Diabetic Retinopathy Treatment Devices Market, by Type, 2015 (USD Mn)
2.2 Diabetic Retinopathy Treatment Drugs Market, by Type, 2015 (USD Mn)
2.3 Diabetic Retinopathy Market Share, by Geography, 2015 (Value %)
Chapter 3 Diabetic Retinopathy Market: Market Dynamics and Outlook
3.1 Introduction
3.2 Diabetic Retinopathy: Facts and Figures
3.3 Drivers
3.4 Challenges
3.5 Future Prospects
3.6 Attractive Investment Proposition
3.1 Competitive Analysis: Market Positioning, by Key Market Players
Chapter 4 Global Diabetic Retinopathy Treatment Devices Market Analysis, by Device Type, 2014-2022 (USD Mn)
4.1 Preface
4.2 Focal Laser Treatment
4.3 Scatter Laser Treatment
4.4 Vitrectomy Devices
Chapter 5 Global Diabetic Retinopathy Drugs Market Analysis, by Drug Type, 2014-2022 (USD Mn)
5.1 Preface
5.2 Aflibercept (Eylea)
5.3 Bevacizumab (Avastin)
5.4 Fluocinolone Acetonide (Iluvien)
5.5 Ranibizumab (Lucentis)
5.6 Triamcinolone Acetonide Injection
Chapter 6 Global Diabetic Retinopathy Market, by Geography, 2014-2022 (USD Mn)
6.1 Preface
6.2 North America
6.2.1 U.S.
6.2.2 Canada
6.3 Europe
6.3.1 U.K.
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia-Pacific
6.4.1 Japan
6.4.2 China
6.4.3 Rest of Asia-Pacific
6.5 Middle East and Africa (MEA)
6.6 Latin America
Chapter 7 Company Profiles
7.1 Alimera Sciences, Inc
7.1.1 Business Description
7.1.2 Financial Health and Budget Allocation
7.1.3 Product Positions/Portfolio
7.1.4 News Coverage
7.2 Pfizer
7.2.1 Business Description
7.2.2 Financial Health and Budget Allocation
7.2.3 Product Positions/Portfolio
7.2.4 News Coverage
7.3 Genentech USA, Inc.
7.3.1 Business Description
7.3.2 Financial Health and Budget Allocation
7.3.3 Product Positions/Portfolio
7.3.4 News Coverage
7.4 Sandoz Inc.
7.4.1 Business Description
7.4.2 Financial Health and Budget Allocation
7.4.3 Product Positions/Portfolio
7.4.4 News Coverage
7.5 Bayer Pharma AG
7.5.1 Business Description
7.5.2 Financial Health and Budget Allocation
7.5.3 Product Positions/Portfolio
7.5.4 News Coverage
7.6 Regeneron Pharmaceuticals Inc.
7.6.1 Business Description
7.6.2 Financial Health and Budget Allocation
7.6.3 Product Positions/Portfolio
7.6.4 News Coverage
7.7 Sirnaomics
7.7.1 Business Description
7.7.2 Financial Health and Budget Allocation
7.7.3 Product Positions/Portfolio
7.7.4 News Coverage
7.8 Iridex Corporation
7.8.1 Business Description
7.8.2 Financial Health and Budget Allocation
7.8.3 Product Positions/Portfolio
7.8.4 News Coverage
7.9 Lumenis
7.9.1 Business Description
7.9.2 Financial Health and Budget Allocation
7.9.3 Product Positions/Portfolio
7.9.4 News Coverage
7.10 Valon Lasers OY
7.10.1 Business Description
7.10.2 Financial Health and Budget Allocation
7.10.3 Product Positions/Portfolio
7.10.4 News Coverage
7.11 Other Notable Players
List of Figures
FIG. 1 Diabetic Retinopathy: Market Segmentation
FIG. 2 Diabetic Retinopathy Treatment Devices, by Type, 2015 (USD Mn)
FIG. 3 Diabetic Retinopathy Treatment Drugs Market, Type, 2015 (USD Mn)
FIG. 4 Diabetic Retinopathy Market Share, by Geography, 2015 (Value %)
FIG. 5 Attractive Investment Proposition, Diabetic Retinopathy Market, 2015
FIG. 6 Competitive Analysis: Market Positioning, by Key Market Players
FIG. 7 Global Focal Laser Treatment Market, 2014 – 2022 (USD Mn)
FIG. 8 Global Scatter Laser Treatment Market, 2014 – 2022 (USD Mn)
FIG. 9 Global Vitrectomy Devices Market, 2014 – 2022 (USD Mn)
FIG. 10 Global Aflibercept (Eylea) Market, 2014 – 2022 (USD Mn)
FIG. 11 Global Bevacizumab (Avastin) Market, 2014 – 2022 (USD Mn)
FIG. 12 Global Fluocinolone Acetonide (Iluvien) Market, 2014 – 2022 (USD Mn)
FIG. 13 Global Ranibizumab (Lucentis) Market, 2014 – 2022 (USD Mn)
FIG. 14 Global Triamcinolone Acetonide Injection Market, 2014 – 2022 (USD Mn)
FIG. 15 U.S. Diabetic Retinopathy Market, 2014 – 2022 (USD Mn)
FIG. 16 U.K. Diabetic Retinopathy Market, 2014 – 2022 (USD Mn)
FIG. 17 Germany Diabetic Retinopathy Market, 2014 – 2022 (USD Mn)
FIG. 18 Rest of Diabetic Retinopathy Market, 2014 – 2022 (USD Mn)
FIG. 19 Japan Diabetic Retinopathy Market, 2014 – 2022 (USD Mn)
FIG. 20 China Diabetic Retinopathy Market, 2014 – 2022 (USD Mn)
FIG. 21 Rest of Asia-Pacific Diabetic Retinopathy Market, 2014 – 2022 (USD Mn)
FIG. 22 Middle East and Africa Diabetic Retinopathy Market, 2014 – 2022 (USD Mn)
FIG. 23 Latin America Diabetic Retinopathy Market, 2014 – 2022 (USD Mn)
List of Tables
TABLE 1 Global Diabetic Retinopathy Treatment Devices Market, by Device Type, 2014 – 2022 (USD Mn)
TABLE 2 Global Diabetic Retinopathy Drugs Market, by Drug Type, 2014 – 2022 (USD Mn)
TABLE 3 Global Diabetic Retinopathy Market, by Geography, 2014 – 2022 (USD Mn)
TABLE 4 North America Diabetic Retinopathy Market, by Country, 2014 – 2022 (USD Mn)
TABLE 5 Canada Diabetic Retinopathy Market, 2014 – 2022 (USD Mn)
TABLE 6 Europe Diabetic Retinopathy Market, by Country, 2014 – 2022 (USD Mn)
TABLE 7 Asia-Pacifc Diabetic Retinopathy Market, by Country, 2014 – 2022 (USD Mn)